Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2025 16:30 ET | Source: Castle Biosciences, Inc.

New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer

Castle Biosciences will share new data on its TissueCypher test for patients with Barrett’s esophagus at DDW 2025.
April 08, 2025 07:00 ET | Source: Castle Biosciences, Inc.

Castle Biosciences Strengthens Commitment to Esophageal Cancer Awareness Through Collaborative Partnerships

Castle is supporting key educational programs and initiatives throughout April in recognition of Esophageal Cancer Awareness Month.
February 01, 2022 09:00 ET | Source: Symple Surgical

Symple Surgical Awarded SBIR Phase I Grant for Novel Radiometry‐Guided Ablation Catheter to Reliably Treat Barrett's Esophagus

FLAGSTAFF, Ariz., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Symple Surgical Inc. (SSI) announced today that it has received a Small Business Innovation Research (SBIR) Phase I grant award totaling...
September 08, 2021 09:00 ET | Source: Cernostics

Cernostics Contracts with Geisinger Health Plan to Become an In-network Provider for TissueCypher® Barrett’s Esophagus Assay

Pittsburgh, PA, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Cernostics, pioneer of the worlds’ first precision medicine test to predict future development risk of esophageal cancer from Barrett’s esophagus...
March 11, 2021 11:00 ET | Source: Aqua Medical

Aqua Medical Announces First-in-Human Experience of RF Vapor Ablation Therapy for Barrett's Esophagus Published in Endoscopy

Santa Ana, CA, March 11, 2021 (GLOBE NEWSWIRE) -- Aqua Medical, developer of the FDA 510(k)-cleared vapor-based endoscopic ablation technology for gastrointestinal disease and GI cancer prevention,...